Related Experiment Video
Updated: Feb 14, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression
Junqing Chen1, Zhanhong Chen1, Jian Huang1
1Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Abstract:
Triple negative breast cancer (TNBC) accounts for approximately 15-20% of all breast cancer cases and is usually more aggressive with a poorer clinical outcome compared with other breast cancer subtypes. Evidence of the involvement of microRNAs (miRNAs) in cancer has provided an opportunity for the development of novel effective therapeutic targets in TNBC. In the present study, the miRNA expression profiles of the human breast cancer cell line, MDA-MB-231, and MCF-7 cells, was evaluated by using miRNA microarray analysis. A total of 107 differentially expressed miRNAs (57 upregulated and 50 downregulated) were identified in MDA-MB-231 cells compared with MCF-7 cells. Five prominently dysregulated miRNAs (miR-200c-3p, miR-221-3p, miR-222-3p, miR-192-5p and miR-146a) were further confirmed by reverse transcription-quantitative polymerase chain reaction. In addition, gene ontology analysis and pathway enrichment analysis revealed that the dysregulated miRNAs and predicted targets were found to be involved in the mitogen-activated protein kinase, Wnt, and transforming growth factor-β signaling pathways, which were known to contribute to TNBC progression and metastasis. Finally, miRNA gene network analyses suggested that miR-200c may serve as a crucial miRNA in breast cancer. Taken together, these findings may provide a comprehensive view of the function of aberrant miRNAs involved in TNBC, and dysregulated miRNAs hold promise as potential biomarkers and therapeutic targets for patients with TNBC.
Insights
Triple negative breast cancer (TNBC) is aggressive, but microRNAs (miRNAs) offer new therapeutic targets. This study identified 107 differentially expressed miRNAs in TNBC cells, highlighting potential biomarkers and treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Triple negative breast cancer (TNBC) represents 15-20% of breast cancers and is associated with aggressive behavior and poor prognosis.
- MicroRNAs (miRNAs) are increasingly recognized for their roles in cancer development and progression, presenting potential therapeutic avenues for TNBC.
- Identifying specific miRNA dysregulations in TNBC is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate and characterize the differential miRNA expression profiles in TNBC cells compared to non-TNBC cells.
- To identify key miRNAs and their associated signaling pathways involved in TNBC progression and metastasis.
- To explore the potential of dysregulated miRNAs as diagnostic biomarkers and therapeutic targets for TNBC.
Main Methods:
- MicroRNA microarray analysis was performed to compare miRNA expression between MDA-MB-231 (TNBC) and MCF-7 (non-TNBC) cell lines.
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to validate the expression levels of selected dysregulated miRNAs.
- Gene ontology and pathway enrichment analyses were conducted to identify the biological functions and signaling pathways associated with the identified miRNAs and their predicted targets.
Main Results:
- A total of 107 differentially expressed miRNAs were identified, with 57 upregulated and 50 downregulated in MDA-MB-231 cells compared to MCF-7 cells.
- Five miRNAs (miR-200c-3p, miR-221-3p, miR-222-3p, miR-192-5p, and miR-146a) were confirmed to be significantly dysregulated.
- The dysregulated miRNAs and their targets were found to be enriched in critical signaling pathways such as MAPK, Wnt, and TGF-β, which are implicated in TNBC progression and metastasis.
- Network analysis suggested miR-200c as a potentially crucial miRNA in breast cancer.
Conclusions:
- Aberrant miRNA expression plays a significant role in the pathogenesis of triple negative breast cancer.
- Dysregulated miRNAs, particularly miR-200c, represent promising candidates for novel biomarkers and therapeutic targets in TNBC.
- Understanding miRNA involvement in key signaling pathways provides insights into TNBC progression and potential treatment strategies.
Related Concept Videos
MicroRNAs
MicroRNAs
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Negative Regulator Molecules
Positive, Negative, and Zero Work

